cs.LGOct 27, 2026

PRISM: Pathology Reliability In Scarce-label Medicine. A Tile-level Benchmark of Pathology Foundation Models

Authors: Alicem Koyun

Organizations: Westcliff University

Abstract

Pathology foundation models are typically benchmarked on classification performance at full label availability and on in-distribution test sets, while calibration, behavior at low label budgets, and robustness under cross-institutional shift are seldom evaluated jointly. We introduce PRISM, a tile-level benchmark that measures the reliability of pathology foundation models along four axes: model choice, label fraction, calibration, and out-of-distribution transfer. PRISM evaluates eight foundation models (CLIP, PLIP, CONCH, UNI, Virchow2, GigaPath, H-Optimus-0, Midnight) on six tile-level datasets at six label fractions (1% to 100%) with three seeds (864 linear probe runs), extended with a five-hospital Camelyon17 study of 20 directed transfer pairs. Four phenomena emerge. (i) Under full supervision, AUROC rank predicts post-temperature calibration rank consistently across datasets (Spearman rho = 0.52, I^2 = 0%), whereas at 1% labels the relationship becomes dataset-specific (rho = -0.24, I^2 = 67%). (ii) On harder datasets the linear probe collapses to a single predicted class below a dataset-specific label fraction. (iii) Whether additional source-domain labels help or harm target calibration tracks how well the probe transfers: below a transfer AUROC of roughly 0.85, more labels worsen target ECE in 86-88% of combinations. (iv) Temperature scaling fails to reduce ECE in 49 of 288 cells, miscalibration is predominantly under-confidence, and a source-fitted temperature is harmful under failing transfer. PRISM is released as a pip-installable package with reference results for all 288 cells. Code and data: https://github.com/alicemkyn/prism-benchmark

Figures & tables

Appendix figures & tables32 assets

Supplementary material from the paper’s appendix.

Appendix

Explore similar work

Jul 5, 2026

The Good, the Bad, and the Brittle: Benchmarking Robustness and Generalisation of Histopathology Foundation Models

How robust and generalisable are pathology foundation models and have their scaling limites been reached? We benchmarked twelve pathology foundation models (PFMs) and ResNet baselines using our Robustness Evaluation and Enhancement Toolbox (REET) across eleven clinically realistic perturbations and a dissimilarity-driven Non-Redundant K-fold validation (NR-Kfold) protocol. We introduce a Perturbation Performance Index (PPI) to summarise accuracy trends under controlled perturbation sweeps and analyse robustness scaling with parameter count. We show that PFMs consistently outperform CNNs in both robustness and domain generalisation, yet model scaling shows diminishing returns: mid-sized models such (UNI2/Virchow-2 etc.) achieve comparable or greater resilience than larger systems. NR-Kfold analysis further reveals systematic accuracy loss and increased variability when training-test similarity is broken, underscoring the need for explicit distribution-shift evaluation. These findings suggest that the next generation of pathology foundation models must prioritise data quality, multimodality information and domain alignment over parameter count to achieve genuine clinical reliability.
Sep 30, 2026

SCALE: Synthetic Calibration via Agreement Labeling in Embedding Space

Foundation models for computational pathology are usually evaluated using AUC and accuracy, while calibration is often left untested. This matters because a model can be accurate on average but still assign overly confident probabilities to cases that are difficult even for pathologists. We study calibration across eight pathology foundation models. Using pathologist agreement as a measure of diagnostic difficulty, we find that calibration error is consistently higher on low-agreement cases than on high-agreement cases. This pattern is not apparent from aggregate expected calibration error (ECE) alone. We then propose synthetic agreement calibration, a method for improving calibration without collecting multi-annotator labels. Given a trained linear probe, we select high-confidence embeddings as class anchors and interpolate between anchors from opposite classes. The interpolation weights encode a continuous notion of diagnostic ambiguity, which we use as a synthetic agreement signal to retrain the probe with agreement-aware label smoothing. On MHIST, which includes annotations from seven pathologists, synthetic agreement calibration recovers most of the calibration improvement obtained by label smoothing based on real pathologist agreement, while substantially reducing low-agreement ECE relative to the uncalibrated baseline. Discrimination metrics are preserved. On PatchCamelyon and BreakHis, public histopathology datasets without multi-annotator labels, the method improves calibration across the evaluated foundation models, whereas annotator-dependent approaches cannot be used without additional expert annotation.
Jul 24, 2026

Robustifying pathology foundation models via fine-tuning

Pathology foundation models (FMs) produce powerful tile-level representations which remain sensitive to scanner and staining variability, undermining deployment across laboratories. We develop a novel fine-tuning recipe that improves the robustness of pathology FMs to acquisition factors. Applied to ten different FMs, our fine-tuning strategy consistently improves robustness for every model as well as downstream performance, with no observed trade-off. On average, it raises the PathoROB robustness index by 23% (from 0.72 to 0.87) and increases the overall cross-benchmark performance by 43% on Patho-Bench, HEST and THUNDER combined, with individual gains reaching up to 72% in robustness (Phikon-v2) and 76% in performance (Midnight-12k). We publicly release the fine-tuned versions of Phikon-v2 (Phaet) and Midnight-12k (Mascaret) at https://huggingface.co/wearewaiv/models.